Brain MRI and Proton MRS Findings in Infants and Children with Respiratory Chain Defects

Abstract

Objective: The aim of this study is to describe neuroimaging patterns in children with respiratory chain (RC) defects using magnetic resonance imaging (MRI) and proton magnetic resonance spectroscopy (MRS) and to assess their role in the diagnostic evaluation. Method: Neuroimaging studies of 49 children (newborn to 15 years old) with biochemical evidence of RC defect were reviewed. Patients were divided in 3 groups (“definite” = 24, “probable” = 14, “possible” = 11) according to Modified Adult Criteria for the diagnosis of RC defect. Eighty-one MRI studies were reviewed for deep gray and white matter changes, degree of myelination, cerebral and cerebellar atrophy, and 67 proton MRS studies were assessed for the presence or absence of lactate elevation, as well as NAA/Cr ratio. The findings were compared among the 3 groups with chi-square test. Results: All patients with “pure” myopathy had normal imaging studies. In patients with CNS involvement, significant differences in the frequency of imaging abnormalities among groups were found for deep gray matter (43 %/8 %/0 %; p = 0.01) and for the presence of lactate elevation on proton MRS (81 %/31 %/0 %; p = 0.001). Conclusion: Brain MRI and proton MRS abnormalities were observed only in association with clinical CNS involvement. Deep gray matter signal abnormalities on structural imaging and lactate elevation on proton MRS were more frequently observed in the “definite” group and represent neuroimaging markers for RC mitochondriopathy.

Mitochondrial encephalomyopathy - respiratory chain defect - childhood - MRI - MRS

References

• 1 Barkovich A J, Good W V, Koch T K, Berg B O. Mitochondrial disorders: analysis of their clinical and imaging characteristics.  AJNR Am J Neuroradiol. 1993;  14 1119-1137
• 2 Berkovic S F, Carpenter S, Evans A, Karpati G, Shoubridge E A, Andermann F, Meyer E, Tyler J L, Diksic M, Arnold D, Wolfe L S, Andermann E, Hakim A M. Myoclonus epilepsy and ragged-red fibres (MERRF). 1. A clinical, pathological, biochemical, magnetic resonance spectrographic and positron emission tomographic study.  Brain. 1989;  112 (Pt 5) 1231-1260
• 3 Bernier F P, Boneh A, Dennett X, Chow C W, Cleary M A, Thorburn D R. Diagnostic criteria for respiratory chain disorders in adults and children.  Neurology. 2002;  59 1406-1411
• 4 Bianchi C M, Tossetti M, Battini R, Manca L M, Mancuso M, Cioni G, Canapicchi R, Siciliano G. Proton MRS of mitochondrial diseases: Analysis of brain metabolic abnormalities and their possible diagnostic relevance.  AJNR Am J Neuroradiol. 2003;  24 1958-1966
• 5 Brockmann K, Dechent P, Meins M, Haupt M, Sperner J, Stephanie U, Frahm J, Hanafeld F. Cerebral proton MRS in infantile Alexander disease.  J Neurol. 2003;  250 300-306
• 6 Castillo M, Kwock L, Green C. MELAS syndrome: Imaging and proton MR spectroscopic findings.  Am J Neuroradiol. 1995;  16 233-239
• 7 Cavanagh B J, Harding N B. Pathogenic factors underlying the lesions in Leigh's disease.  Brain. 1994;  117 1357-1376
• 8 de Lonlay-Debeney P, von Kleist-Retzow J C, Hertz-Pannier L, Peudenier S, Cormier-Daire V, Berquin P, Chretien D, Rotig A, Saudubray J M, Baraton J, Brunelle F, Rustin P, Van Der Knaap M, Munnich A. Cerebral white matter disease in children may be caused by mitochondrial respiratory chain deficiency.  J Pediatr. 2000;  136 209-214
• 9 DiMauro S. Mitochondrial diseases.  Biochim Biophys Acta. 2004;  1658 80-88
• 10 Farina L, Chiapparini L, Uziel G, Bugiani M, Zeviani M, Savoiardo M. MR findings in Leigh Syndrome with COX deficiency and SURF‐1 mutation.  Am J Neuroradiol. 2002;  23 1095-1100
• 11 Kang P B, Hunter J V, Kaye E M. Lactic acid elevation in extramitochondrial childhood neurodegenerative diseases.  J Child Neurol. 2001;  16 657-660
• 12 Kapeller P, Fazekas F, Offenbacher H, Stollberger R, Schmidt R, Bergloff J, Radner H, Fazekas G, Schafhalter-Zoppoth I. Magnetic resonance imaging and spectroscopy of progressive cerebral involvement in Kearns Sayre syndrome.  J Neurol Sci. 1996;  135 126-130
• 13 Kaufmann P, Shungu D C, Sano M C, Jhung S, Engelstad K, Mitsis E, Mao X, Shanske S, Hirano M, DiMauro S, De Vivo D C. Cerebral lactic acidosis correlates with neurological impairment in MELAS.  Neurology. 2004;  62 1297-1302
• 14 Kirby D M, Crawford M, Cleary M A, Dahl H HM, Dennet X, Thorburn D R. Respiratory chain complex I deficiency. An underdiagnosed energy generation disorder.  Neurology. 1999;  52 1255-1264
• 15 Krageloh-Mann I, Grodd W, Schoning M, Marquard K, Nagele T, Ruitenbeek W. Proton spectroscopy in five patients with Leigh's disease and mitochondrial enzyme deficiency.  Dev Med Child Neurol. 1993;  35 769-776
• 16 Krahenbuhl S, Talco C, Wiesmann U, Hoppel C L. Development and evaluation of a spectrophotometric assay for complex III in isolated mitochondria, tissues and fibroblasts from rats and humans.  Clin Chim Acta. 1994;  230 177-187
• 17 Lammont P J, Surtees R, Woodward C E, Leonard J V, Wood N W, Harding A E. Clinical and laboratory findings in referral for mitochondrial DNA analysis.  Arch Dis Child. 1998;  79 22-27
• 18 Lin D D, Crawford T O, Barker P B. Proton MR spectroscopy in the diagnostic evaluation of mitochondrial disease.  AJNR Am J Neuroradiol. 2003;  24 33-44
• 19 Lindner A, Hofmann E, Naumann M, Becker G, Reichmann H. Clinical, morphological, biochemical, and neuroradiological features of mitochondrial encephalomyopathies. Presentation of 19 patients.  Mol Cell Biochem. 1997;  174 297-303
• 20 Mathews P M, Andermann F, Silver K, Karpati G, Arnold D L. Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies.  Neurology. 1993;  43 2484-2490
• 21 Moroni I, Bugiani M, Bizzi A, Castelli G, Lamantea E, Uziel G. Cerebral white matter involvement in children with mitochondrial encephalopathies.  Neuropediatrics. 2002;  33 79-85
• 22 Munoz A, Mateos F, Simon R, Garcia-Silva M T, Cabello S, Arenas J. Mitochondrial diseases in children: neuroradiological and clinical features in 17 patients.  Neuroradiology. 1999;  41 920-928
• 23 Nishino I, Spinazzola A, Papadimitriou A, Hammans S, Steiner I, Hahn C D, Connolly A M, Verloes A, Guimaraes J, Maillard I, Hamano H, Donati M A, Semrad C E, Russell J A, Andreu A L, Hadjigeorgiou G M, Vu T H, Tadesse S, Nygaard T G, Nonaka I, Hirano I, Bonilla E, Rowland L P, DiMauro S, Hirano M. Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations.  Ann Neurol. 2000;  47 792-800
• 24 Papadimitriou A, Comi G P, Hadjigeorgiou G M, Bordoni A, Sciacco M, Napoli L, Prelle A, Moggio M, Fagiolari G, Bresolin N, Salani S, Anastasopoulos I, Giassakis G, Divari R, Scarlato G. Partial depletion and multiple deletions of muscle mtDNA in familial MNGIE syndrome.  Neurology. 1998;  51 1086-1092
• 25 Powers J M, DeVivo D C. Peroxisomal and mitochondrial disorders. Graham DI, Lantos PL Greenfield's Neuropathology. London; Arnold 2002: 758-797
• 26 Scaglia F, Towbin J A, Craigen W J, Belmont J W, Smith E O, Neish S R, Ware S M, Hunter J V, Fernbach S D, Vladutiu G D, Wong L J, Vogel H. Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease.  Pediatrics. 2004;  114 925-931
• 27 Shoubridge E A. Nuclear genetic defects of oxidative phosphorylation.  Hum Mol Genet. 2001;  10 2277-2284
• 28 Sparaco M, Bonilla E, DiMauro S, Powers J M. Neuropathology of mitochondrial encephalomyopathies due to mitochondrial DNA defects.  J Neuropathl Exp Neurol. 1993;  52 1-10
• 29 Szigeti K, Sule N, Adesina A M, Armstrong D L, Saifi G M, Bonilla E, Hirano M, Lupski J R. Increased blood-brain barrier permeability with thymidine phosphorylase deficiency.  Ann Neurol. 2004;  56 881-886
• 30 Thorburn D R, Smeitink J. Diagnosis of mitochodrial disorders: Clinical and biochemical approach.  J Inherit Metab Dis. 2001;  24 312-316
• 31 Valanne L, Ketonen L, Majander A, Suomalainen A, Pihko H. Neuroradiologic findings in children with mitochondrial disorders.  AJNR Am J Neuroradiol. 1998;  19 369-377
• 32 van der Knaap M S, Kamphorst W, Barth P G, Kraaijeveld C L, Gut E, Valk J. Phenotypic variation in leukoencephalopathy with vanishing white matter.  Neurology. 1998;  51 540-547
• 33 van der Knaap M S, van der Voorn P, Barkhof F, Van Coster R, Krageloh-Mann I, Feigenbaum A, Blaser S, Vles J S, Rieckmann P, Pouwels P J. A new leukoencephalopathy with brainstem and spinal cord involvement and high lactate.  Ann Neurol. 2003;  53 252-258
• 34 Wolf N I, Smeitink J A. Mitochondrial disorders: a proposal for consensus diagnostic criteria in infants and children.  Neurology. 2002;  59 1402-1405
• 35 Wray S H, Provenzale J M, Johns D R, Thulborn K R. MR of the brain in mitochondrial myopathy.  Am J Neuroradiol. 1995;  16 1167-1173
• 36 Zafeiriou D I, Koletzko B, Mueller-Felber W, Paetzke I, Kueffer G, Jensen M. Deficiency in complex IV (cytochrome c oxidase) of the respiratory chain, presenting as a leukodystrophy in two siblings with Leigh syndrome.  Brain Dev. 1995;  17 117-121